GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Rightongene Biotechnology Co Ltd (SHSE:688217) » Definitions » Capital Expenditure

Shanghai Rightongene Biotechnology Co (SHSE:688217) Capital Expenditure : ¥-47.35 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Rightongene Biotechnology Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shanghai Rightongene Biotechnology Co's cash flow for capital expenditures for the three months ended in Sep. 2024 was ¥-6.8 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-47.35 Mil.

Shanghai Rightongene Biotechnology Co Capital Expenditure Historical Data

The historical data trend for Shanghai Rightongene Biotechnology Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rightongene Biotechnology Co Capital Expenditure Chart

Shanghai Rightongene Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -53.83 -52.14 -95.60 -106.57 -109.09

Shanghai Rightongene Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.90 -32.36 -2.90 -5.35 -6.75

Shanghai Rightongene Biotechnology Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-47.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rightongene Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Rightongene Biotechnology Co Ltd (SHSE:688217) » Definitions » Capital Expenditure
Comparable Companies
SZSE:000004 SHSE:688163 BJSE:839729 BJSE:837344 SZSE:300871 SZSE:002872 SHSE:688189 SZSE:002566 SZSE:002873 SZSE:002286 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 6055, Jinhai Road, Building 3, Fengxian District, Shanghai, CHN, 201499
Website
http://www.rightongene.com
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Executives
Ke Zhong He Core technical personnel

Shanghai Rightongene Biotechnology Co Headlines

No Headlines